MalarVx, Inc.

SEC filing

Biotechnology · Seattle, WA

Form D on EDGAR

Amount raised$125Ksold at filing

Total offering$2.5M$2.4M still open

Investors in the raise2count reported to the SEC

FiledAug 25, 2026first sale Aug 8, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jodi n/a HerczegExecutive Officer

James n/a DavieDirector

Executive officers, directors and promoters as listed on the Form D.